|
IntrinsiQ Buys WWMR
Jun 12, 2009 (Close-Up Media via COMTEX) --
IntrinsiQ, the company improving the quality and understanding of cancer care, announced the acquisition of market research and consulting firm WWMR.
IntrinsiQ said that the combination creates the single, go-to source for pharmaceutical companies seeking to understand the true drivers behind physicians' cancer treatment decisions to navigate today's fast-moving, high-stakes medical oncology market.
Through this acquisition, IntrinsiQ reported that it now offers a complete suite of primary and secondary oncology market research capabilities to provide validated insight into how oncologists perceive treatment standards - and how they actually practice medicine. For the first time, primary research panels can be quickly assembled and tightly aligned with IntrinsiQ's real-time database of more than 600 oncologists nationwide and their practice behavior.
Founded 15 years ago, WWMR brings deep expertise in oncology research, having established and served as the secondary market research arm of Genentech for the past decade. The boutique firm specializes in qualitative and quantitative market research, product and market assessments, forecasts, and economic analysis conducted through every stage of the clinical research and drug development process.
"As oncology treatment becomes more complex and more specialized, the stakes get raised on pharmaceutical teams' sizeable R&D investment," said Mike Raquet, general manager of IntrinsiQ's pharmaceutical information division. "WWMR brings deep understanding and immediate access to doctors on the front lines - the best way for pharmaceutical companies to affirm strategic directions sooner, and with greater assurances for ROI."
Twenty-seven of the top 30 pharmaceutical oncology organizations rely on IntrinsiQ's database of 2 million drug administrations given annually, collected from oncology practices nationwide using IntrinsiQ's flagship clinical oncology software, IntelliDose.
"This alignment is a perfect marriage because of our organizations' shared mission of improving the quality and understanding of cancer care," said Susan Olsen, WWMR founder and president, who becomes vice president, consulting services in IntrinsiQ's pharmaceutical information division. "IntrinsiQ has long been the gold standard in oncology data, and we're thrilled to join their team."
WWMR will retain its name and maintain offices in San Mateo, California. All WWMR employees will join IntrinsiQ. The firm also will continue to offer its custom consulting and market research services in non-oncology markets, including patient panels in chronic pain, cardiology and cystic fibrosis, as well as its Neuropathic, Cancer, and Back Pain reports.
((Comments on this story may be sent to newsdesk@closeupmedia.com))
[ Back To TMCnet.com's Homepage ]
|
SUBSCRIPTIONS
Activate Email 
TMCnet LOGIN
Find Solutions for Enterprises, SMBs & Service Providers at the INTERNET TELEPHONY Conference and EXPO West, October 4-6, 2010. Los Angeles, CA.
